Kiniksa (KNSA) CAO receives options, RSUs, PSUs and adds to shareholdings
Rhea-AI Filing Summary
Kiniksa Pharmaceuticals International, plc chief accounting officer Michael R. Megna reported multiple equity compensation transactions. On April 1, 2026, he received a share option for 14,600 shares at an exercise price of $48.13, vesting over four years starting April 1, 2026.
He was also granted 3,650 Restricted Share Units and 7,300 Performance Share Units, each tied to Class A Ordinary Shares and subject to multi‑year time- and performance-based vesting. The filing shows RSU exercises converting into 7,564 Class A Ordinary Shares, with 3,205 shares withheld at $48.13 to cover tax obligations.
Following these transactions, Megna directly holds 31,777 Class A Ordinary Shares. Footnotes describe prior participation in the 2018 Employee Share Purchase Plan and detail vesting schedules for the options, RSUs, and PSUs, including potential PSU settlement by January 30, 2029 based on performance.
Positive
- None.
Negative
- None.
Insights
Routine equity grants and vesting for Kiniksa’s CAO, no open‑market trades.
The transactions reflect standard executive compensation rather than discretionary buying or selling. Michael R. Megna received a 14,600-share option at $48.13, 3,650 RSUs, and 7,300 PSUs, all linked to Class A Ordinary Shares with multi‑year vesting schedules.
Several existing RSU awards partially vested, converting into 7,564 shares, while 3,205 shares were withheld at $48.13 to satisfy tax obligations. This F‑code disposition is not an open‑market sale and carries limited signaling value about Megna’s view of KNSA.
After these actions, he holds 31,777 shares directly, indicating the equity awards meaningfully increase his stock-based exposure. Future company filings may update on PSU performance outcomes and remaining unvested awards, but these items together look like routine compensation administration.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Share Option | 14,600 | $0.00 | -- |
| Grant/Award | Restricted Share Unit | 3,650 | $0.00 | -- |
| Grant/Award | Performance Share Unit | 7,300 | $0.00 | -- |
| Exercise | Restricted Share Unit | 2,558 | $0.00 | -- |
| Exercise | Restricted Share Unit | 2,362 | $0.00 | -- |
| Exercise | Restricted Share Unit | 2,644 | $0.00 | -- |
| Exercise | Class A Ordinary Share | 7,564 | $0.00 | -- |
| Tax Withholding | Class A Ordinary Share | 3,205 | $48.13 | $154K |
| Grant/Award | Class A Ordinary Share | 372 | $24.16 | $9K |
Footnotes (1)
- The reporting person is voluntarily reporting the acquisition of these shares pursuant to the Issuer's 2018 Employee Share Purchase Plan for the purchase period of July 16, 2025 to January 15, 2026. The acquisition of these shares was exempt pursuant to Rule 16b-3(e). Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April 1, 2026. The RSUs vest over a four-year period, with 25% of the RSUs vesting on the vesting commencement date of April 1, 2026, and each yearly anniversary thereafter. Each Performance Share Unit (PSU) represents a contingent right to receive a number of Class A Ordinary Shares of the Issuer based upon the achievement of certain pre-established performance criteria, as certified by the Issuer's Compensation Committee. Unless earlier forfeited, each PSU vests and converts into not more than 200% of one Class A Ordinary Share of the Issuer no later than January 30, 2029, unless such date falls on a non-business date, in which case the next business date shall apply. The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2023. The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2024. The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2025.